Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913105
rs121913105
FGFR3
C 0.700 CausalMutation CLINVAR

dbSNP: rs121913482
rs121913482
FGFR3
T 0.700 CausalMutation CLINVAR

dbSNP: rs121913483
rs121913483
FGFR3
G 0.700 CausalMutation CLINVAR

dbSNP: rs28931614
rs28931614
FGFR3
A 0.700 CausalMutation CLINVAR

dbSNP: rs28933068
rs28933068
FGFR3
G 0.700 CausalMutation CLINVAR

dbSNP: rs28934571
rs28934571
TP53
A 0.700 CausalMutation CLINVAR

dbSNP: rs4647924
rs4647924
FGFR3
G 0.700 CausalMutation CLINVAR

dbSNP: rs1058808
rs1058808
ERBB2
0.010 GeneticVariation BEFREE <b>Conclusions:</b> Our results suggested that the combination of <i>HER2</i> rs1136201and rs1058808 was significantly associated with the susceptibility of CCa. 30719131

2019
dbSNP: rs9277535
rs9277535
HLA-DPB1
0.020 GeneticVariation BEFREE <i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer. 30009173

2018
dbSNP: rs3117027
rs3117027
HLA-DPB2
0.720 GeneticVariation BEFREE <i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer. 30009173

2018
dbSNP: rs1048943
rs1048943
CYP1A1
0.090 GeneticVariation BEFREE (2) rs1048943 (CYP1A1 A4889G) showed the strongest association with cervical cancer in the allele effect model (1.83[1.57, 2.13]); in addition, rs1048943 (CYP1A1 A4889G) had a very strong association in the dominant and recessive effect model. 25928231

2015
dbSNP: rs1217691063
rs1217691063
MTHFR
0.100 GeneticVariation BEFREE Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis. 23070908

2013
dbSNP: rs1217691063
rs1217691063
MTHFR
0.100 GeneticVariation BEFREE C677T polymorphism of MTHFR gene may increase the risk of cervical cancer in the complete over-dominant model. 23490201

2013
dbSNP: rs4646903
rs4646903
CYP1A1
0.050 GeneticVariation BEFREE rs4646903 minor alleles and interaction between rs4646903 and rs1048943 were associated with increased cervical cancer risk. 27265845

2016
dbSNP: rs1292037
rs1292037
VMP1 ; MIR21
0.010 GeneticVariation BEFREE In addition to that, the G allele at rs1292037 (A > G) locus increases the risk of preoperative chemoresistance to cisplatin plus paclitaxel and is a poor prognostic factor for patients with CC. 30447706

2018
dbSNP: rs9277952
rs9277952 		0.720 GeneticVariation GWASCAT A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. 23817570

2013
dbSNP: rs3918242
rs3918242
MMP9
0.010 GeneticVariation BEFREE A hospital-based case-control study was conducted in 230 patients with cervical cancer and 230 healthy controls to investigate the possible association between the MMP2 rs243865, MMP3 rs3025058, MMP7 rs11568818, and MMP9 rs3918242 polymorphisms, respectively, and the risk of cervical cancer. 26526578

2016
dbSNP: rs1042522
rs1042522
TP53
0.100 GeneticVariation BEFREE A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors. 25181402

2015
dbSNP: rs1131691014
rs1131691014
TP53
0.100 GeneticVariation BEFREE A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors. 25181402

2015
dbSNP: rs878854066
rs878854066
TP53
0.100 GeneticVariation BEFREE A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors. 25181402

2015
dbSNP: rs1353702185
rs1353702185
MDM2
0.010 GeneticVariation BEFREE A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors. 25181402

2015
dbSNP: rs1057519911
rs1057519911
MAPK1
0.010 GeneticVariation BEFREE A recent exome-sequencing study revealed prevalent mitogen-activated protein kinase 1 (MAPK1) p.E322K mutation in cervical carcinoma. 26548627

2016
dbSNP: rs55859133
rs55859133
MAPK3
0.010 GeneticVariation BEFREE A recent exome-sequencing study revealed prevalent mitogen-activated protein kinase 1 (MAPK1) p.E322K mutation in cervical carcinoma. 26548627

2016
dbSNP: rs1800797
rs1800797
IL6 ; STEAP1B ; IL6-AS1
0.010 GeneticVariation BEFREE A significant association of CxCa with various polymorphisms was observed: rs1800797 in the IL-6 gene (odds ratio [OR] = 0.88, 95% confidence intervals [CI]: 0.79-0.99); rs1041981 in the LTA gene (OR = 0.87, 95% CI: 0.78-0.98), and rs9344 in the CCND1 gene (OR = 1.14, 95% CI: 1.02-1.27), for those individuals carrying the rare allele. 19585495

2009
dbSNP: rs1041981
rs1041981
LTA ; LOC100287329
0.010 GeneticVariation BEFREE A significant association of CxCa with various polymorphisms was observed: rs1800797 in the IL-6 gene (odds ratio [OR] = 0.88, 95% confidence intervals [CI]: 0.79-0.99); rs1041981 in the LTA gene (OR = 0.87, 95% CI: 0.78-0.98), and rs9344 in the CCND1 gene (OR = 1.14, 95% CI: 1.02-1.27), for those individuals carrying the rare allele. 19585495

2009